Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-009617
Filing Date
2025-07-25
Accepted
2025-07-25 16:34:45
Documents
87
Period of Report
2025-05-31

Document Format Files

Seq Description Document Type Size
1 10-K cydy-20250531x10k.htm   iXBRL 10-K 2353749
2 EX-19.1 cydy-20250531xex19d1.htm EX-19.1 234146
3 EX-21 cydy-20250531xex21.htm EX-21 3600
4 EX-23.1 cydy-20250531xex23d1.htm EX-23.1 5345
5 EX-23.2 cydy-20250531xex23d2.htm EX-23.2 3738
6 EX-31.1 cydy-20250531xex31d1.htm EX-31.1 9398
7 EX-31.2 cydy-20250531xex31d2.htm EX-31.2 9305
8 EX-32 cydy-20250531xex32.htm EX-32 6306
9 GRAPHIC cydy-20250531x10k004.jpg GRAPHIC 12020
  Complete submission text file 0001558370-25-009617.txt   10149425

Data Files

Seq Description Document Type Size
10 EX-101.SCH cydy-20250531.xsd EX-101.SCH 81150
11 EX-101.CAL cydy-20250531_cal.xml EX-101.CAL 72229
12 EX-101.DEF cydy-20250531_def.xml EX-101.DEF 266639
13 EX-101.LAB cydy-20250531_lab.xml EX-101.LAB 553932
14 EX-101.PRE cydy-20250531_pre.xml EX-101.PRE 462116
90 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20250531x10k_htm.xml XML 1734933
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-49908 | Film No.: 251152084
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)